drugset / Trial / NCT00359632

Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater

NCT00359632

Phase 3 Terminated 34 enrolled Pfizer
Non-randomizedParallel-groupOpen-label

Summary

To understand and characterize the effects of linezolid on the optic nerve by observing and following patients who have been treated with linezolid for six weeks or longer for the development of signs or symptoms of visual disturbance or eye disorders.

Timeline

Start
2008-11
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Linezolid Other / unclassified 600 mg

Indications